Patents by Inventor Peter SINNAEVE

Peter SINNAEVE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10704097
    Abstract: The present invention relates to diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score in relation to the cardiovascular events, more particular after intervention, can be determined by counting the number of deregulated genes (or derived proteins) in their isolated monocytes. Deregulation means low expression of COX1 and/or COX4I1, and/or TFAM, and/or RUNX2.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: July 7, 2020
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Paul Holvoet, Stefan Janssens, Peter Sinnaeve
  • Publication number: 20170016071
    Abstract: The present invention relates to diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score in relation to the cardiovascular events, more particular after intervention, can be determined by counting the number of deregulated genes (or derived proteins) in their isolated monocytes. Deregulation means low expression of COX1 and/or COX4I1, and/or TFAM, and/or RUNX2.
    Type: Application
    Filed: August 26, 2016
    Publication date: January 19, 2017
    Inventors: Paul HOLVOET, Stefan JANSSENS, Peter SINNAEVE